Ocera
Ocera is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class small molecule therapeutics for the treatment of acute (hospital-based) and chronic gastrointestinal (GI) motility disorders.

Investment year: 2001
Industry sector: Biotechnology
Region: Quebec
Fund:
Healthcare Venture Fund